Osteoporosis Trial, Recruiting NCT07187518 Sponsor: POROUS GmbH Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT07187518
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female or male, aged between 21 and 55 years (inclusive)
  • People who have given written agreement to take part in the trial

Who may not be able to join:

  • People who have conditions that would interfere with bone scanning measurements, such as fractures, metal implants in the bones being examined, paralysis of the lower limbs, or severe bone abnormalities
  • People who have open wounds or skin infections at the area of the body where the ultrasound device would be used
  • People who are unable to complete the required study procedures, or who have cognitive difficulties that would prevent them from understanding the participant information and consent documents
  • People who are currently pregnant or breastfeeding
  • People who are being held in custody by order of a legal authority or court
  • People who have a close connection to the research site, such as being employed there, being a close relative of one of the researchers, or being in a dependent relationship with the site (for example, a student of the investigating institution)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gabriele Armbrecht, MD, PhD, Charite University, Berlin, Germany

Phone: +49 176 34448596

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
POROUS GmbH
Registry
ClinicalTrials.gov
Start date
14 November 2025
Est. completion
30 September 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Primary Clinical Endpoint - POROUS; Primary Clinical Endpoint - DXA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov